More articles from MTA I: GI-Non-colorectal Posters

You have access
Comparison between fluorine-18 fluorodeoxyglucose PET/CT (PET) and contrast enhancement Computed Tomography (ceCT) for staging in esophageal cancer
Stefano Panareo, Corrado Cittanti, Ivan Santi, Chiara Peterle, Valentina de Cristofaro and Luciano Feggi

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1401;
You have access
Predictive value of Intra tumor heterogeneity on baseline ¹⁸F-FDG PET images in esophageal cancer.
Pierrick Gouel, Paul Desbordes, Frederic Di Fiore, Pierre Vera and Romain Modzelewski

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1403;
You have access
A prospective trial for the evaluation of esophageal cancer patients: FDG PET/CT vs. c.e.CT vs. FDG PET/c.e.CT
Laura Evangelista, Anna Cervino, Fabio Pomerri, Carlo Castoro, Vanna Sileni Chiarion and Giorgio Saladini

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1402;
You have access
Clinical utility of delayed regional PET/CT after water distension for evaluating locoregional disease of gastric cancer
Bom Sahn Kim

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1404;
You have access
Diagnostic Value of FDG PET/CT in Differentiation of autoimmune pancreatitis from pancreatic cancer
Zhang Jian and Guorong Jia

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1406;
You have access
Assessment of lymph node metastases using 18F-FDG PET/CT and contrast enhanced CT in patients with esophageal cancer
Andrej Doma, Matevž Srpčič, Daša Šfiligoj and Marko Grmek

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1400;
You have access
Does metabolic activity on FDG PET-CT predict clinical behavior of pancreatic adenocarcinoma (PAC)?
Zaid Haddadin, Bhasker Koppula, Jeffrey Yap, John Hoffman and Kathryn Morton

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1410;
You have access
FDG PET analysis of treatment response in patients with pancreatic adenocarcinoma randomized to preoperative therapy with or without hydroxychloroquine.
Kinzya Grant, Herbert Zeh, Jennifer Miller, Charles Laymon, Michael Lotze and James Mountz

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1408;
You have access
Utility of FDG PET based volumetric metabolic parameters (VMP) in predicting overall survival of patients with stage III/ IV primary gall bladder carcinoma (PGBC)
Arun Reddy, Harpreet Singh, Rajender Kumar, Anish Bhattacharya, Ashwani Sood and Bhagwant Rai Mittal

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1413;
You have access
Associations of iodine content obtained from dual-energy contrast-enhanced CT and texture features or volumetric parameters on FDG PET in pancreatic cancer
Mitsuaki Tatsumi, Makoto Sakane, Hiromitsu Onishi, Kayako Isohashi, Mana Ishibashi and Jun Hatazawa

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1412;

Main menu

User menu

Search

More articles from MTA I: GI-Non-colorectal Posters

Pages